The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks. In this ...

In a report released today, Jessica Tassan from Piper Sandler maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” fourth quarter 2024 investor ...

Exxon Mobil ticked down 2.8% even though the energy giant posted a stronger fourth quarter profit than Wall Street had forecast. Exxon credited increased production in the U.S. Permian basin and in ...

Shares of The Cigna Group traded about 0.8% lower in volatile action Monday morning as Wall Street analysts continued to ...

Shares of Cigna (NYSE: CI) were dropping Thursday. While Cigna's Q4 revenue of $65.65 billion beat Wall Street's estimate of $63.44, rising medical costs led to a much more significant earnings ...

Leading health insurer Cigna Group Inc. (NYSE: CI) was praised for having the foresight to divest its Medicare Advantage (MA) ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Shares of Cigna Group CI slipped 2.07% to $287.23 Thursday, on what proved to be an all-around mixed trading session for the ...

Piper Sandler restated their overweight rating on shares of The Cigna Group (NYSE:CI – Free Report) in a research note published on Monday morning,Benzinga reports. Piper Sandler currently has a $348.